FindTrial
Sign In

Trulicity 0.75 mg solution for injection in pre-filled pen

DRUG3 trials

Sponsors

Bellvitge University Hospital, Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL, Comenius University Bratislava

Conditions

Metabolic syndrome in patients on the waiting list for kidney transplantationPatients with confirmed multiple sclerosis (MS)Preventive treatment of post-kidney transplant diabetesin productive age between 18 and 60 yearswho at the time of investigation are on baseline therapy of the disease for at least 3 monthswith EDSS<5with worse prognosis given the higher disease activity

Phase 2

Effects of GLP-1 analogue in multiple sclerosis
Not yet recruitingCTIS2024-519235-42-00
Comenius University Bratislavain productive age between 18 and 60 years, Patients with confirmed multiple sclerosis (MS), who at the time of investigation are on baseline therapy of the disease for at least 3 months +2
Target: 1Updated: 2024-11-07

Phase 3

GLP-1 receptor agonists as preventive treatment of diabetes after renal transplantation: a single-arm interventional clinical trial. Study 2: Patients on the waiting list for kidney transplantation.
RecruitingCTIS2023-506436-33-00
Bellvitge University Hospital, Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELLMetabolic syndrome in patients on the waiting list for kidney transplantation
Start: 2024-03-22Target: 20Updated: 2025-09-08
GLP-1 receptor agonists as preventive treatment of diabetes after renal transplantation: randomized clinical trial. Study 1: Immediate Kidney Transplant Recipients
RecruitingCTIS2023-506437-29-00
Bellvitge University Hospital, Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELLPreventive treatment of post-kidney transplant diabetes
Start: 2023-12-19Target: 128Updated: 2025-09-12